• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

在急诊科过量使用丁丙诺啡。

Utilizing Buprenorphine in the Emergency Department after Overdose.

机构信息

Institute for Drug and Alcohol Studies, Virginia Commonwealth University, Richmond, VA, USA.

Institute for Drug and Alcohol Studies, Virginia Commonwealth University, Richmond, VA, USA.

出版信息

Trends Pharmacol Sci. 2018 Dec;39(12):998-1000. doi: 10.1016/j.tips.2018.10.002.

DOI:10.1016/j.tips.2018.10.002
PMID:30454771
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6953478/
Abstract

The United States is currently in the midst of an opioid epidemic. Barriers to treatment in the emergency department can lead to missed opportunities for helping prevent overdose and relapse in individuals with opioid use disorder. The administration of buprenorphine in the emergency department can potentially lead to better treatment outcomes for these individuals.

摘要

美国目前正处于阿片类药物泛滥的困境之中。在急诊科治疗的障碍可能会导致错过帮助预防阿片类药物使用障碍患者发生过量用药和复发的机会。在急诊科使用丁丙诺啡可能会为这些患者带来更好的治疗效果。

相似文献

1
Utilizing Buprenorphine in the Emergency Department after Overdose.在急诊科过量使用丁丙诺啡。
Trends Pharmacol Sci. 2018 Dec;39(12):998-1000. doi: 10.1016/j.tips.2018.10.002.
2
Acute Care, Prescription Opioid Use, and Overdose Following Discontinuation of Long-Term Buprenorphine Treatment for Opioid Use Disorder.急性治疗、处方阿片类药物使用以及在停止长期丁丙诺啡治疗阿片类药物使用障碍后出现的药物过量。
Am J Psychiatry. 2020 Feb 1;177(2):117-124. doi: 10.1176/appi.ajp.2019.19060612. Epub 2019 Dec 2.
3
Legal Authority for Emergency Medical Services to Increase Access to Buprenorphine Treatment for Opioid Use Disorder.法律授权紧急医疗服务机构增加美沙酮治疗阿片类药物使用障碍的机会。
Ann Emerg Med. 2021 Jul;78(1):102-108. doi: 10.1016/j.annemergmed.2021.01.017. Epub 2021 Mar 27.
4
Tele-buprenorphine for emergency department overdose visit follow up and treatment initiation.远程丁丙诺啡用于急诊过量就诊的随访和治疗启动。
Am J Emerg Med. 2021 Dec;50:409-412. doi: 10.1016/j.ajem.2021.08.071. Epub 2021 Aug 28.
5
Emergency Department Initiation of Buprenorphine for Opioid Use Disorder: Current Status, and Future Potential.急诊科阿片类药物使用障碍丁丙诺啡的应用：现状和未来潜力。
CNS Drugs. 2019 Dec;33(12):1147-1154. doi: 10.1007/s40263-019-00667-7.
6
US ED Opioid-Related Visits Increase, While Use of Medication for Opioid Use Disorder Undetectable, 2011-2016.2011 - 2016年期间，美国急诊科与阿片类药物相关的就诊人数增加，而用于阿片类药物使用障碍的药物使用情况难以察觉。
J Gen Intern Med. 2020 Mar;35(3):965-966. doi: 10.1007/s11606-019-05249-3.
7
Association of buprenorphine retention and subsequent adverse outcomes following non-fatal overdose: An analysis using statewide linked Maryland databases.丁丙诺啡保留与非致命性过量后不良后果的关联：使用马里兰州全州关联数据库的分析。
Drug Alcohol Depend. 2024 May 1;258:111281. doi: 10.1016/j.drugalcdep.2024.111281. Epub 2024 Apr 3.
8
Primary Care and the Opioid-Overdose Crisis - Buprenorphine Myths and Realities.初级保健与阿片类药物过量危机——丁丙诺啡的误区与真相
N Engl J Med. 2018 Jul 5;379(1):1-4. doi: 10.1056/NEJMp1802741.
9
Responding to the opioid and overdose crisis with innovative services: The recovery community center office-based opioid treatment (RCC-OBOT) model.应对阿片类药物和过量危机的创新服务：康复社区中心门诊阿片类药物治疗（RCC-OBOT）模式。
Addict Behav. 2019 Nov;98:106031. doi: 10.1016/j.addbeh.2019.106031. Epub 2019 Jun 21.
10
As Overdoses Climb, Emergency Departments Begin Treating Opioid Use Disorder.随着过量用药情况攀升，急诊科开始治疗阿片类药物使用障碍。
JAMA. 2018 Jun 5;319(21):2158-2160. doi: 10.1001/jama.2018.4648.

引用本文的文献

1
Emergency department buprenorphine program: staff concerns and recommended implementation strategies.急诊科丁丙诺啡项目：工作人员的担忧及推荐的实施策略
Implement Sci Commun. 2024 Sep 27;5(1):104. doi: 10.1186/s43058-024-00649-x.
2
Age and racial and ethnic disparities in filled buprenorphine prescriptions post-emergency department visit in Nevada.内华达州急诊科就诊后丁丙诺啡处方填充方面的年龄、种族和民族差异。
J Am Coll Emerg Physicians Open. 2024 Sep 6;5(5):e13272. doi: 10.1002/emp2.13272. eCollection 2024 Oct.
3
Emergency department strategies to combat the opioid crisis in children and adolescents.急诊科应对儿童和青少年阿片类药物危机的策略。
J Am Coll Emerg Physicians Open. 2021 Jul 21;2(4):e12512. doi: 10.1002/emp2.12512. eCollection 2021 Aug.
4
Advancing emergency department-initiated buprenorphine.推进急诊科启动的丁丙诺啡治疗。
J Am Coll Emerg Physicians Open. 2021 Jun 16;2(3):e12451. doi: 10.1002/emp2.12451. eCollection 2021 Jun.
5
Evaluation of an emergency department-based opioid overdose survivor intervention: Difference-in-difference analysis of electronic health record data to assess key outcomes.评价基于急诊科的阿片类药物过量幸存者干预措施：电子健康记录数据的差异分析评估关键结局。
Drug Alcohol Depend. 2021 Apr 1;221:108595. doi: 10.1016/j.drugalcdep.2021.108595. Epub 2021 Feb 15.
6
Replication of an emergency department-based recovery coaching intervention and pilot testing of pragmatic trial protocols within the context of Indiana's Opioid State Targeted Response plan.在印第安纳州阿片类药物州目标应对计划的背景下，基于急诊的康复辅导干预措施的复制以及实用临床试验方案的试点测试。
J Subst Abuse Treat. 2020 Jan;108:88-94. doi: 10.1016/j.jsat.2019.06.002. Epub 2019 Jun 6.
7
Progress in agonist therapy for substance use disorders: Lessons learned from methadone and buprenorphine.物质使用障碍激动剂治疗的进展：美沙酮和丁丙诺啡的经验教训。
Neuropharmacology. 2019 Nov 1;158:107609. doi: 10.1016/j.neuropharm.2019.04.015. Epub 2019 Apr 19.

本文引用的文献

1
Identification, Management, and Transition of Care for Patients With Opioid Use Disorder in the Emergency Department.在急诊科识别、管理和过渡护理患有阿片类药物使用障碍的患者。
Ann Emerg Med. 2018 Oct;72(4):420-431. doi: 10.1016/j.annemergmed.2018.04.007. Epub 2018 Jun 5.
2
Characterization and Management of Patients with Heroin versus Nonheroin Opioid Overdoses: Experience at an Academic Medical Center.海洛因与非海洛因类阿片过量患者的特征及管理：一所学术医疗中心的经验
Pharmacotherapy. 2017 Jul;37(7):781-790. doi: 10.1002/phar.1902. Epub 2017 Feb 27.
3
Emergency department-initiated buprenorphine/naloxone treatment for opioid dependence: a randomized clinical trial.急诊科启动的丁丙诺啡/纳洛酮治疗阿片类药物依赖：一项随机临床试验。
JAMA. 2015 Apr 28;313(16):1636-44. doi: 10.1001/jama.2015.3474.
4
A review of buprenorphine diversion and misuse: the current evidence base and experiences from around the world.丁丙诺啡转移与滥用综述：当前的证据基础及全球经验
J Addict Med. 2014 Sep-Oct;8(5):315-26. doi: 10.1097/ADM.0000000000000045.
5
Buprenorphine-naloxone buccal soluble film for the treatment of opioid dependence: current update.用于治疗阿片类药物依赖的丁丙诺啡 - 纳洛酮口腔可溶性薄膜：最新进展
Expert Opin Drug Deliv. 2015 Feb;12(2):339-47. doi: 10.1517/17425247.2014.953479. Epub 2014 Aug 25.
6
Safety and health policy considerations related to the use of buprenorphine/naloxone as an office-based treatment for opiate dependence.与使用丁丙诺啡/纳洛酮作为阿片类药物依赖的门诊治疗相关的安全与健康政策考量。
Drug Alcohol Depend. 2003 May 21;70(2 Suppl):S79-85. doi: 10.1016/s0376-8716(03)00061-9.
7
Therapeutic alliance and psychiatric severity as predictors of completion of treatment for opioid dependence.治疗联盟和精神疾病严重程度作为阿片类药物依赖治疗完成情况的预测指标。
Psychiatr Serv. 1999 Feb;50(2):219-27. doi: 10.1176/ps.50.2.219.
8
Acute administration of buprenorphine in humans: partial agonist and blockade effects.丁丙诺啡在人体中的急性给药：部分激动剂和阻断作用。
J Pharmacol Exp Ther. 1995 Jul;274(1):361-72.